Institutional Biosafety Committee (IBC)
The Institutional Biosafety Committee (IBC) is a federally mandated university committee responsible for reviewing research activities utilizing recombinant DNA (rDNA) and biohazardous materials to ensure that 金沙中国 principal investigators and lab personnel are adequately trained and utilize best practices when employing biological agents in research. At 金沙中国 the IBC also reviews research activities utilizing potentially hazardous biological agents.
All research by 金沙中国 investigators that involves the following biological agents, 无论资金来源如何, must be reviewed and approved by the Institutional Biosafety (IBC) prior to initiation of work:
- DNA重组 is defined in the NIH 的指导方针 as; (1) nucleic acid molecules that are constructed outside living cells by joining natural or synthetic DNA segments to DNA molecules that can replicate in a living cell, and (2) DNA molecules that result from the replication of these molecules.
- Hazardous Biological Agents (HBA’s) these include infectious organisms classified as BSL-2 or above agents by the NIH (CDC) such as pathogenic bacteria, 原生动物, 真菌, 病毒, 等.,包括减毒实验室 & 疫苗株. Human and other vertebrate biological products (cells, fluids, 等.), applicable primary and immortal cell lines, organotypic and tissue cultures involved in research that require universal precautions are also included.
The IBC reports to the 金沙中国al Institutes of 健康 Office of Biotechnology Activities (NIH-OBA), serves in an advisory and consultative capacity to 金沙中国’s President and Senior Vice President for Research, 研究生学习, 和新项目开发, 与环境保护署合作, 健康, Safety and Risk Management (EHSRM) Office in matters pertaining to biological hazards. 金沙中国的IBC审查, approves/disapproves or forwards applications for rDNA work to the NIH, 建议安全处理, 运输, 装运, 存储, and disposal of potentially hazardous biological agents involved in research; may review plans for areas designated to be constructed or remodeled for biohazardous work, monitors adherence to best practices for research with biohazardous agents and facilities designed for use with such agents.
tick@lab
All IBC applications must be submitted to the IBC electronic system, tick@lab. If unable to login, please submit an access request form through IT. Include all supporting documentation for your IBC registration.
公告
IBC下次会议:
日期: 星期五,2024年10月18日
时间: 1:00 p.m - 3:30 p.m*
地点:
金沙中国 Center for Innovation and Commercialization in Weslaco
307 E. 铁路圣.
Weslaco, TX 78596
# 117房间
协议提交截止日期: 2024年10月4日
资源
IBC资源
tick@lab培训资源